Daniel Myran

Adjunct Scientist ICES uOttawa Mental Health & Addictions Research Program

Biography

Dr. Myran is a public health and family medicine physician and researcher. His program of research involves using health administrative data to examine the burden and societal impact of mental health conditions and substance use. His primary focus is examining the health impacts of changes in alcohol and drug policies and their influence on health inequities. As a secondary area of interest he uses big data to examine the health of physicians in Ontario.

CCFP, Family Medicine, University of Ottawa
FRCPC, Public Health and Preventive Medicine, University of Ottawa
MPH, Quantitative Methods, Harvard University
MD, Western University

Drug policy
Mental health and addictions
Public health
Epidemiology

Investigator, Bruyere Research Institute
Assistant Professor, Department of Family Medicine, University of Ottawa
Associate Scientist, Ottawa Hospital Research Institute

Awards & Recognition

13/03/2024

Tier 2 Canada Research Chair in Social Accountability

2024: Awarded to Dr. Daniel Myran. The research goal is to examine the health consequences of substance use including an in-depth examination of the health impact of alcohol and drug policy in Canada.

Awards & Recognition

25/03/2023

Early Career Researcher of the Year – Public Health and Epidemiology

2023: Awarded to Dr. Daniel Myran by the University of Ottawa Faculty of Medicine.

Awards & Recognition

15/06/2018

Gareth M. Green Award

2018: Awarded to Dr. Daniel Myran by the Harvard T. H. Chan School of Public Health.

See All

Journal Articles

Journal Article

17/09/2024

Adverse outcomes and mortality in individuals with eating disorder-related electrolyte abnormalities in Ontario, Canada: a population-based cohort study

Solmi M, Fabiano N, Clarke AE, Fung SG, Tanuseputro P, Knoll G, Myran DT, Bugeja A, Sood MM, Hundemer GL. Lancet Psychiatry. 2024; 11:818–27.

Journal Article

25/08/2024

Mental health service use among mothers and other birthing parents during the COVID-19 pandemic in Ontario, Canada

Webber C, Dover K, Tanuseputro P, Vigod SN, Moineddin R, Clarke A, Isenberg S, Fiedorowicz JG, Jin Y, Gandhi J, Simpson AN, Barker LC, Kendall CE, Myran D. J Affect Disord. 2024; 367:913-922. Epub 2024 Aug 25.

Journal Article

14/08/2024

Physician follow-up of pediatric and young adult emergency department visits for substance use in Ontario, Canada

Rosic T, Cloutier P, Myran D, Imsirovic H, Kurdyak P, Gardner W. J Adolesc Health. 2024; S1054-139X(24)00303-3. Epub 2024 Aug 14.

Journal Article

13/06/2024

Changes in cannabis involvement in emergency department visits for anxiety disorders after cannabis legalization: a repeated cross-sectional study

McCarthy SDS, Xiao J, Pugliese M, Perrault-Sequeira L, Myran DT. Lancet Reg Health Am. 2024; 36:100815. Epub 2024 Jun 13.

Journal Article

10/06/2024

COVID-19 vaccine uptake among Ontario physicians: a descriptive population-based retrospective cohort study

Liu CW, Jeyakumar N, McArthur E, Sontrop JM, Myran DT, Schwartz KL, Sood MM, Tanuseputro P, Garg AX. BMJ Open. 2024; 14(6):e080461. Epub 2024 Jun 10.

Journal Article

29/05/2024

The association between alcohol retail access and health care visits attributable to alcohol for individuals with and without a history of alcohol-related health-care use

Myran DT, Friesen E, Talarico R, Gaudreault A, Taljaard M, Hobin E, Smith BT, Schwartz N, Giesbrecht N, Crépault J-F, Tanuseputro P, Manuel DG. 2024; May 28 [Epub ahead of print].

Journal Article

05/02/2024

Development of an anxiety disorder following an emergency department visit due to cannabis use: a population-based cohort study

Myran DT, Harrison LD, Pugliese M, Tanuseputro P, Gaudreault A, Fiedorowicz JG, Solmi M. EClinicalMedicine. 2024; Feb 5 [Epub ahead of print].

Journal Article

01/02/2024

Cannabis-involvement in emergency department visits for self-harm following medical and non-medical cannabis legalization

Myran DT, Gaudreault A, Pugliese M, Tanuseputro P, Saunders N. J Affect Disord. 2024; Feb 1 [Epub ahead of print].

Journal Article

14/12/2023

Mortality in adolescents and young adults following a first presentation to the emergency department for alcohol

Harrison LD, Dumicho AY, Bader Eddeen A, Tanuseputro P, Kendall CE, Fiedorowicz JG, Rosic T, Fernando SM, McNaughton CD, Corace K, Kurdyak P, Beckerleg W, Webber C, Gardner W, Sood M, Myran DT.

Journal Article

10/12/2023

Impact of non-medical cannabis legalization with market restrictions on health service use and incident cases of psychotic disorder in Ontario, Canada

Anderson KK, Rodrigues R, Le B, Mamun M, Archie S, Edwards J, Elton-Marshall T, Gilliland J, Myran DT, Palaniyappan L, Perlman CM, Seabrook JA, Murray RM, Shariff SZ. Int J Drug Policy. 2023; Dec 10 [Epub ahead of print].

See All

News Coverage

News Release

17/09/2024

Get in touch with
Daniel Myran

"*" indicates required fields

Daniel Myran

Biography

Education

Research Focus

Other Affiliations

Awards & Recognition

Tier 2 Canada Research Chair in Social Accountability

Early Career Researcher of the Year – Public Health and Epidemiology

Gareth M. Green Award

Journal Articles

Adverse outcomes and mortality in individuals with eating disorder-related electrolyte abnormalities in Ontario, Canada: a population-based cohort study

Mental health service use among mothers and other birthing parents during the COVID-19 pandemic in Ontario, Canada

Physician follow-up of pediatric and young adult emergency department visits for substance use in Ontario, Canada

Changes in cannabis involvement in emergency department visits for anxiety disorders after cannabis legalization: a repeated cross-sectional study

COVID-19 vaccine uptake among Ontario physicians: a descriptive population-based retrospective cohort study

The association between alcohol retail access and health care visits attributable to alcohol for individuals with and without a history of alcohol-related health-care use

Development of an anxiety disorder following an emergency department visit due to cannabis use: a population-based cohort study

Cannabis-involvement in emergency department visits for self-harm following medical and non-medical cannabis legalization

Mortality in adolescents and young adults following a first presentation to the emergency department for alcohol

Impact of non-medical cannabis legalization with market restrictions on health service use and incident cases of psychotic disorder in Ontario, Canada

News Coverage

Abnormal electrolyte levels in people with eating disorders may increase risk of death, poor health outcomes

Heavy cannabis use increases risk of developing an anxiety disorder, study suggests

Emergency department visits for substance use linked to higher risk of developing schizophrenia

Commercialization of cannabis linked to increased traffic injuries

Get in touch with
Daniel Myran

Daniel Myran

Biography

Education

Research Focus

Other Affiliations

Awards & Recognition

Tier 2 Canada Research Chair in Social Accountability

Early Career Researcher of the Year – Public Health and Epidemiology

Gareth M. Green Award

Journal Articles

Adverse outcomes and mortality in individuals with eating disorder-related electrolyte abnormalities in Ontario, Canada: a population-based cohort study

Mental health service use among mothers and other birthing parents during the COVID-19 pandemic in Ontario, Canada

Physician follow-up of pediatric and young adult emergency department visits for substance use in Ontario, Canada

Changes in cannabis involvement in emergency department visits for anxiety disorders after cannabis legalization: a repeated cross-sectional study

COVID-19 vaccine uptake among Ontario physicians: a descriptive population-based retrospective cohort study

The association between alcohol retail access and health care visits attributable to alcohol for individuals with and without a history of alcohol-related health-care use

Development of an anxiety disorder following an emergency department visit due to cannabis use: a population-based cohort study

Cannabis-involvement in emergency department visits for self-harm following medical and non-medical cannabis legalization

Mortality in adolescents and young adults following a first presentation to the emergency department for alcohol

Impact of non-medical cannabis legalization with market restrictions on health service use and incident cases of psychotic disorder in Ontario, Canada

News Coverage

Abnormal electrolyte levels in people with eating disorders may increase risk of death, poor health outcomes

Heavy cannabis use increases risk of developing an anxiety disorder, study suggests

Emergency department visits for substance use linked to higher risk of developing schizophrenia

Commercialization of cannabis linked to increased traffic injuries

Get in touch with Daniel Myran

Get in touch with
Daniel Myran